While EBV serology and EBER-ISH remain central to NPC diagnosis and surveillance, CK19 immunohistochemistry may provide additional value in morphologically ambiguous biopsies, particularly when used alongside pan-cytokeratin panels. The gene discussed is KRT19; the disease is nasopharyngeal carcinoma.